Cargando…
Docetaxel immunonanocarriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studies
BACKGROUND: The objective of this study was to develop pegylated poly lactide-co-glycolide acid (PLGA) immunonanocarriers for targeting delivery of docetaxel to human breast cancer cells. METHODS: The polyethylene glycol (PEG) groups on the surface of the PLGA nanoparticles were functionalized using...
Autores principales: | Koopaei, Mona Noori, Dinarvand, Rassoul, Amini, Mohsen, Rabbani, Hojatollah, Emami, Shaghayegh, Ostad, Seyed Nasser, Atyabi, Fatemeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173052/ https://www.ncbi.nlm.nih.gov/pubmed/21931485 http://dx.doi.org/10.2147/IJN.S23211 |
Ejemplares similares
-
Docetaxel Loaded PEG-PLGA Nanoparticles: Optimized Drug Loading, In-vitro Cytotoxicity and In-vivo Antitumor Effect
por: Noori Koopaei, Mona, et al.
Publicado: (2014) -
Enhanced Oral Delivery of Docetaxel Using Thiolated Chitosan Nanoparticles: Preparation, In Vitro and In Vivo Studies
por: Saremi, Shahrooz, et al.
Publicado: (2013) -
Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation
por: Saremi, Shahrooz, et al.
Publicado: (2011) -
Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles
por: Esfandyari-Manesh, Mehdi, et al.
Publicado: (2015) -
Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel
por: Manoochehri, Saeed, et al.
Publicado: (2013)